SEEING WHAT MATTERS

We support radiologists with our AI-based tools during MRI reportings. This enables them to perform more precise and objective assessments even more quickly.

— Product Innovation: AI for Prostate Diagnosis

YOUR SOLUTION FOR AUTOMATED PROSTATE DIAGNOSIS

Our latest CE-certified product enables AI-based evaluations of prostate MRIs. Lesions are automatically detected and classified according to PI-RADS 2.1.

— Our AI-based solutions

YOUR SOFTWARE FOR MRI ASSESSMENTS FROM HEAD TO KNEE.

Sharpen your focus and save time in your daily routine, seamlessly integrated into your workflow.

Everything at a glance in your PACS

Fast analysis of MRI images integrated in your workflow

Automatically generated reports incl. norm value comparison

Highest security for your data through local hosting

Customers who trust in us.

YOUR SOLUTION FOR QUANTITATIVE NEURO-IMAGING.

Our advanced tool for the AI-based evaluation of your brain MRIs. Provides security and saves valuable time - certified and tested hundreds of thousands of times in the daily radiological routine.

Saves time on tedious tasks

through automatic segmentation of physiological structures

Dementia
Multiple sclerosis
MSA/CBD/PSA

More safety in case of critical findings

through automatic detection of pathological structures

Glioma/Glioblastoma
Metastasis
Meningioma

Saves time on tedious tasks

through automatic segmentation of physiological structures

More safety in case of critical findings

through automatic detection of pathological structures

Our md-suite is compatible with all common PACS providers. In addition, we are working on deeper integrations with numerous other partners.

— About mediaire

WHAT SETS
US APART.

From radiologists
for radiologists

Our products are all developed in close cooperation with radiologists. This is how we ensure that your requirements are met.

Optimized for the daily routine in radiology

Our products are proven in daily routine of hospitals and medical practices. There, high precision and fair pricing allow for large scale applications.

Highest spectrum of MRI applications on the market

Our md-suite already offers a wide range of applications. However we constantly develop new products to make your daily life even easier.

— Scientific evidence

AI in facts and figures

Automated Detecion of Cerebral Aneurysms on TOF-MRA Using A Deep-Learning Approach: An External Validation Study (American Journal Of Neuroradiology, 2022)

Triplanar U-Net with Lesion-wise Voting for the Segmentation of New Lesions on Longitudinal MRI Studies (Frontiers in Neuroscience, 2022)

Real-life evaluation of the AI-based neuroradiology suite mdbrain (Congress of the European Society of Radiology, 2022)

Segmentation of MS Lesions Accuracy of mdbrain 4.5 versus a pool of human experts (Congress of the European Society of Radiology, 2022)

We offer a transparent and flexible pricing model. You pay according to volume. Without risk. No hidden costs.

Test our software free of charge and without obligation!

We offer a transparent and flexible pricing model. You pay according to volume. Without risk. No hidden costs.

Test our software
free of charge and
without obligation!

— News & Press

Dienstag, 27.07.2022

Crazy days in Rome at #AINR – our suite #mdbrain has attracted huge interest and our booth was always crowded. Moreover first local experience showing gains in diagnostic precision and efficiency was presented!

Mittwoch, 01.07.2022

Crazy days in Rome at #AINR – our suite #mdbrain has attracted huge interest and our booth was always crowded. Moreover first local experience showing gains in diagnostic precision and efficiency was presented!

Freitag, 03.05.2022

mediaire and SECTRA work together to make AI-based solutions like mdbrain available to customers globally. The full growth potential and better address the needs of large internationally operating clients.

Cooperation with the bender Group for the Detection of Micrometastases

The bender Group, 100% owner of medigration GmbH, an established RIS/PACS company, is collaborating with mediaire on the development of AI image recognition software for Ferrotran®. The MRI contrast agent by SPL Medical BV, with the bender group as majority stakeholder, is currently in the final phase of clinical approval studies. With the creation of mdprostate, mediaire brings extensive experience in the development of AI image recognition software for prostate cancer to the partnership.

Find out more

Don't hesitate
to get in touch!


Don't hesitate
to get in touch!


Solutions

*bald verfügbar 

mediaire GmbH

Möckernstrasse 63
10965 Berlin, Germany

P +49 30 286 490 67
F +49 30 286 490 66

© 2022 mediaire GmbH

WORLD PREMIERE AT ECR 2024

Experience mdprostatethe first fully-automated AI-tool including longitudinal assessment for the evaluation of prostate MRIs.

mediaire GmbH

Möckernstrasse 63
10965 Berlin, Germany

P +49 30 286 490 67
F +49 30 286 490 66

© 2022 mediaire GmbH